Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Dhanvantri Jeevan Rekha Ltd met on 14 November 2025 (3:00 PM to 4:00 PM) and approved the un-audited financial results for the quarter and half-year ended 30 September 2025. The reviewed results, along with the limited review report, have been attached and will also be published in newspapers as required under SEBI (LODR) Regulations. The company, which operates Dhanvantri Hospital in Meerut, has submitted this intimation to BSE under Regulation 30. No specific financial numbers or performance figures are disclosed in this filing.
This is a routine regulatory filing confirming board approval of quarterly results; investors should look at the actual attached financial results for any meaningful takeaways on revenue, profit, or other performance metrics.